MEDP - メッドペ―ス・ホ―ルディングス （Medpace Holdings Inc.） メッドペ―ス・ホ―ルディングスMEDPのチャート
MEDPの企業情報
| symbol | MEDP |
|---|---|
| 会社名 | Medpace Holdings Inc （メッドペ―ス・ホ―ルディングス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Commercial Physical_Biological Resarch |
| 業種 | バイオテクノロジ―_メディカルリサ―チ IT・通信（IT_Communications） |
| 概要 | 事業概要 メッドペース・ホールディングス(Medpace Holdings Inc.)は臨床契約研究機関である。同社は臨床研究に基づく医薬品及び医療機器開発サービスを提供する。同社は医薬品、バイオ技術、および医療機器企業と協力して、臨床試験の開発・実施を行う。同社の麻薬開発サービスは、フルサービス第I-IV臨床開発サービスを主として、開発計画の設計、コーディネートされた中央検査室、プロジェクト管理、規制業務、臨床モニタリング、データ管理および分析、薬物動態検査の新薬申請の提出、および販売後のマーケティング臨床サポートを含む。また、バイオアナリティカルラボサービス、臨床ヒト薬理学、イメージングサービス、および臨床試験のための心電図読み取りのサポートを提供する。同社の事業は、主に北米、欧州、アジアに拠点を置く。 メッドペ―ス・ホ―ルディングスは米国の臨床試験受託企業。持株会社体制で、子会社を通じ臨床試験サ―ビスをバイオ医薬品企業や医療器具メ―カ―などの医療業界全体に提供する。主に心臓病、代謝性疾患、がん、内分泌系疾患、神経系疾患などに対する臨床試験をフェ―ズ1からフェ―ズ4まで実施する。本社はオハイオ州シンシナティ。 Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries. |
| 本社所在地 | 5375 Medpace Way Cincinnati OH 45227 USA |
| 代表者氏名 | August J. Troendle 8月J.Troendle |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 513-579-9911 |
| 設立年月日 | 41671 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2016年 |
| 従業員数 | 2500人 |
| url | www.medpace.com |
| nasdaq_url | https://www.nasdaq.com/symbol/medp |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 118.75300 |
| 終値（lastsale） | 57 |
| 時価総額（marketcap） | 2027575728 |
| 時価総額 | 時価総額（百万ドル） 1865.725 |
| 売上高 | 売上高（百万ドル） 556.54600 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 232.587 |
| 当期純利益 | 当期純利益（百万ドル） 49.25000 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Medpace Holdings Inc revenues increased 57% to $333.2M. Net income applicable to common stockholders increased 72% to $31M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Amortization decrease of 22% to $14.8M (expense) Miscellaneous (expense) income net increase from $497K (expense) to $325K (income). |
MEDPのテクニカル分析
MEDPのニュース
Medpace Holdings Stock: Priced With High Expectations (NASDAQ:MEDP) 2023/04/01 12:44:59 Seeking Alpha
Cincinnati-based Medpace provides the biotechnology world with Phase 1-IV clinical development services using scientifically driven research. Read more about MEDP here.
WASATCH ADVISORS INC Buys 3, Sells 2 in 4th Quarter 2023/02/18 12:00:35 GuruFocus
Related Stocks: AIMC , ABCM , MEDP , FOXF , GWRE ,
Medpace files for automatic shelf offering 2023/02/14 23:01:23 Seeking Alpha
Medpace Holdings (MEDP) has filed for an automatic shelf offering.The filing does not necessarily indicate that a sale has begun, or will occur in the future.The company noted that it…
Medpace Holdings, Inc. (MEDP) Q4 2022 Earnings Call Transcript 2023/02/14 18:06:02 Seeking Alpha
Medpace Holdings, Inc. (NASDAQ:NASDAQ:MEDP) Q4 2022 Earnings Conference Call February 14, 2023 9:00 AM ETCompany ParticipantsLauren Morris - IRAugust Troendle - CEOJesse Geiger -…
Medpace Holdings, Inc. 2022 Q4 - Results - Earnings Call Presentation (NASDAQ:MEDP) 2023/02/14 15:10:06 Seeking Alpha
The following slide deck was published by Medpace Holdings, Inc.
WASATCH ADVISORS INC Buys 3, Sells 2 in 4th Quarter 2023/02/18 12:00:35 GuruFocus
Related Stocks: AIMC , ABCM , MEDP , FOXF , GWRE ,
Medpace files for automatic shelf offering 2023/02/14 23:01:23 Seeking Alpha
Medpace Holdings (MEDP) has filed for an automatic shelf offering.The filing does not necessarily indicate that a sale has begun, or will occur in the future.The company noted that it…
Medpace Holdings, Inc. (MEDP) Q4 2022 Earnings Call Transcript 2023/02/14 18:06:02 Seeking Alpha
Medpace Holdings, Inc. (NASDAQ:NASDAQ:MEDP) Q4 2022 Earnings Conference Call February 14, 2023 9:00 AM ETCompany ParticipantsLauren Morris - IRAugust Troendle - CEOJesse Geiger -…
Medpace Holdings, Inc. 2022 Q4 - Results - Earnings Call Presentation (NASDAQ:MEDP) 2023/02/14 15:10:06 Seeking Alpha
The following slide deck was published by Medpace Holdings, Inc.
Medpace: Q4 Earnings Snapshot 2023/02/13 22:09:01 WTOP
CINCINNATI (AP) — CINCINNATI (AP) — Medpace Holdings Inc. (MEDP) on Monday reported fourth-quarter net income of $68.7 million. The…
S&P 500, Nasdaq Break Key Levels, But Watch These 5 Stocks; Netflix Subscriber Growth Strong 2023/01/19 21:47:06 Investor''s Business Daily
The S&P 500 and Nasdaq fell below their 50-day lines. Medpace and Exxon lead resilient stocks. Netflix jumped late as subscriber growth easily beat views.
Companies - SG Americas Securities LLC Sells 1,012 Shares of Medpace Holdings, Inc 2023/01/17 11:17:11 Business Mag
SG Americas Securities LLC lessened its holdings in shares of Medpace Holdings, Inc. by 11.1% during the 3rd quarter, according to its most recent filing with the Securities…
Positioning For Medpace Into FY22'' Earnings (NASDAQ:MEDP) 2023/01/15 05:33:21 Seeking Alpha
Heading into its FY22 earnings in Feb., Medpace Holdings'' share price has caught another bid. Find out why are we continuing to rate MEDP a buy.